Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Prontosan wound gel for prevention of peritoneal dialysis exit-site infection
2006-006928-18Phase 4Terminated
- Sponsor
- Barts Health NHS Trust
- Start
- Jan 2007
- Modality
- Classical Binding Small Molecules → Small Molecules, Covalent Small Molecules → Small Molecules, Nucleic Acid-Directed Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, open-label trial of polihexanide and mupirocin in catheter infection, peritoneal dialysis exit-site infection (ESI) and peritonitis (2 arms), sponsored by Barts Health NHS Trust. Primary endpoints: Exit-site and tunnel catheter infection rate, Peritonitis rate and 2 more. Started Jan 2007; status: terminated.
02
Drugs
polihexanidemupirocin
03
Conditions
catheter infectionperitoneal dialysis exit-site infection (ESI)peritonitis
Beyond the preview
Go deeper on 2006-006928-18.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2006-006928-18.